A new study shows that patients who initiated treatment with blood pressure or cholesterol medications were more likely to reduce activity and gain weight.
Genentech announced new 1-year data from the SUNFISH trial evaluating risdiplam in spinal muscular atrophy.
Fresenius Kabi’s glucagon emergency kit is a cost-effective alternative to branded kit products.
Efficient Laboratories, Inc. is voluntarily recalling 1 lot each of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAXliquid products due to microbial contamination.
An Ohio law allowing pharmacists to dispense naloxone without a prescription was linked to a significant increase in naloxone dispensing rates, especially in low-employment areas.
The FDA posted results of its NDMA lab analysis of metformin products in the United States.
A supplemental application for cannabidiol oral solution (Epidiolex, GW Pharmaceuticals and Greenwich Biosciences) has been submitted for the treatment of seizures associated with tuberous sclerosis complex.
Baricitinib (Olumiant, Eli Lilly and Incyte) demonstrated positive results in the BREEZE-AD5 study of patients with atopic dermatitis.
A Publix Pharmacy under construction at a hospital in Daytona Beach, Florida, will help Publix Super Markets continue its expansion into the hospital pharmacy realm.
Eli Lilly’s lasmiditan (Reyvow) C-V 50 mg and 100 mg for the acute treatment of migraine is now available for prescription.